Clinical Trials for NewAmsterdam Pharma

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: NewAmsterdam Pharma

Clinical Trials (6)

NCT07219602
A Randomized Phase 3 Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
PHASE3Not yet recruiting
300 participants
Started: Dec 31, 2025 · Completed: Jun 30, 2028
3 conditions1 sponsor0 locations
NCT06982508
Evaluation of Obicetrapib on Antioxidant Levels in Plasma and HDL Particles of Healthy Volunteers
PHASE2Recruiting
100 participants
Started: Sep 9, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06496243
Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels
PHASE2Recruiting
69 participants
Started: Dec 2, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06305559
A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
PHASE3Recruiting
300 participants
Started: May 16, 2024 · Completed: Mar 31, 2027
3 conditions1 sponsor1 location
NCT05972278
Investigating the Effect of Obicetrapib on Lipoprotein Metabolism
PHASE1Active, not recruiting
22 participants
Started: Dec 1, 2023 · Completed: Oct 14, 2024
1 condition2 sponsors1 location
NCT05202509
Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease
PHASE3Active, not recruiting
9,541 participants
Started: Feb 7, 2022 · Completed: Nov 30, 2026
1 condition2 sponsors591 locations